55 related articles for article (PubMed ID: 9865726)
1. High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.
Roberge M; Berlinck RG; Xu L; Anderson HJ; Lim LY; Curman D; Stringer CM; Friend SH; Davies P; Vincent I; Haggarty SJ; Kelly MT; Britton R; Piers E; Andersen RJ
Cancer Res; 1998 Dec; 58(24):5701-6. PubMed ID: 9865726
[TBL] [Abstract][Full Text] [Related]
2. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
3. [Potentiation of radiosensitivity by staurosporine associated with abrogation of G2 phase arrest].
Sun XC; Wang JJ; Zhen YS; Shao RG
Yao Xue Xue Bao; 2002 Jun; 37(6):419-23. PubMed ID: 12579796
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.
Jiang X; Zhao B; Britton R; Lim LY; Leong D; Sanghera JS; Zhou BB; Piers E; Andersen RJ; Roberge M
Mol Cancer Ther; 2004 Oct; 3(10):1221-7. PubMed ID: 15486189
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of the G2 DNA damage checkpoint and their potential for cancer therapy.
Anderson HJ; Andersen RJ; Roberge M
Prog Cell Cycle Res; 2003; 5():423-30. PubMed ID: 14593736
[TBL] [Abstract][Full Text] [Related]
6. New okadaic acid analogues from the marine sponge Merriamum oxeato and their effect on mitosis.
Britton R; Roberge M; Brown C; van Soest R; Andersen RJ
J Nat Prod; 2003 Jun; 66(6):838-43. PubMed ID: 12828471
[TBL] [Abstract][Full Text] [Related]
7. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control.
Strunz AM; Peschke P; Waldeck W; Ehemann V; Kissel M; Debus J
Int J Radiat Biol; 2002 Aug; 78(8):721-32. PubMed ID: 12194756
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint.
Stuschke M; Sak A; Wurm R; Sinn B; Wolf G; Stüben G; Budach V
Int J Radiat Biol; 2002 Sep; 78(9):807-19. PubMed ID: 12428922
[TBL] [Abstract][Full Text] [Related]
9. Induction of p21CIP/WAF-1 and G2 arrest by ionizing irradiation impedes caspase-3-mediated apoptosis in human carcinoma cells.
Wendt J; Radetzki S; von Haefen C; Hemmati PG; Güner D; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2006 Feb; 25(7):972-80. PubMed ID: 16331277
[TBL] [Abstract][Full Text] [Related]
10. Improved synthesis of isogranulatimide, a G2 checkpoint inhibitor. Syntheses Of didemnimide C, isodidemnimide A, neodidemnimide A, 17-methylgranulatimide, and isogranulatimides A-C.
Piers E; Britton R; Andersen RJ
J Org Chem; 2000 Jan; 65(2):530-5. PubMed ID: 10813968
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53.
Li JN; Gorospe M; Chrest FJ; Kumaravel TS; Evans MK; Han WF; Pizer ES
Cancer Res; 2001 Feb; 61(4):1493-9. PubMed ID: 11245456
[TBL] [Abstract][Full Text] [Related]
12. Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer.
Zhao H; Spitz MR; Tomlinson GE; Zhang H; Minna JD; Wu X
Cancer Res; 2001 Nov; 61(21):7819-24. PubMed ID: 11691798
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.
Kohn EA; Yoo CJ; Eastman A
Cancer Res; 2003 Jan; 63(1):31-5. PubMed ID: 12517773
[TBL] [Abstract][Full Text] [Related]
14. Implication of the G2 checkpoint in the maintenance of genome integrity.
Piette J; Muñoz P
Pathol Biol (Paris); 2000 Apr; 48(3):174-81. PubMed ID: 10858951
[TBL] [Abstract][Full Text] [Related]
15. Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells.
Andreassen PR; Lacroix FB; Lohez OD; Margolis RL
Cancer Res; 2001 Oct; 61(20):7660-8. PubMed ID: 11606409
[TBL] [Abstract][Full Text] [Related]
16. P53 pathways involving G2 checkpoint regulators and the role of their subcellular localisation.
Winters ZE
J R Coll Surg Edinb; 2002 Aug; 47(4):591-8. PubMed ID: 12363184
[TBL] [Abstract][Full Text] [Related]
17. Marine pyrrolocarbazoles and analogues: synthesis and kinase inhibition.
Deslandes S; Chassaing S; Delfourne E
Mar Drugs; 2009 Dec; 7(4):754-86. PubMed ID: 20098609
[TBL] [Abstract][Full Text] [Related]
18. Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach.
Williams DE; Andersen RJ
Nat Prod Rep; 2020 May; 37(5):617-633. PubMed ID: 31750842
[TBL] [Abstract][Full Text] [Related]
19. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
Sun LC; Qian HX
Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
[TBL] [Abstract][Full Text] [Related]
20. A Survey of Marine Natural Compounds and Their Derivatives with Anti-cancer Activity Reported in 2012.
Sawadogo WR; Boly R; Cerella C; Teiten MH; Dicato M; Diederich M
Molecules; 2015 Apr; 20(4):7097-142. PubMed ID: 25903364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
